First Manhattan’s Ironwood Pharmaceuticals IRWD Stock Holding History

First Manhattan’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-28,758	Closed	-$277K	–	1505
2023 Q3	$277K	Buy	28,758 +13,833	+93%	+$136K	﹤0.01%	601
2023 Q2	$159K	Hold	14,925	–	–	﹤0.01%	689
2023 Q1	$157K	Hold	14,925	–	–	﹤0.01%	727
2022 Q4	$185K	Hold	14,925	–	–	﹤0.01%	714
2022 Q3	$154K	Hold	14,925	–	–	﹤0.01%	734
2022 Q2	$172K	Hold	14,925	–	–	﹤0.01%	742
2022 Q1	$187K	Hold	14,925	–	–	﹤0.01%	770
2021 Q4	$174K	Hold	14,925	–	–	﹤0.01%	772
2021 Q3	$194K	Hold	14,925	–	–	﹤0.01%	740
2021 Q2	$192K	Hold	14,925	–	–	﹤0.01%	741
2021 Q1	$166K	Hold	14,925	–	–	﹤0.01%	738
2020 Q4	$169K	Hold	14,925	–	–	﹤0.01%	687
2020 Q3	$134K	Hold	14,925	–	–	﹤0.01%	712
2020 Q2	$154K	Hold	14,925	–	–	﹤0.01%	694
2020 Q1	$150K	Buy	14,925 +1,000	+7%	+$11.8K	﹤0.01%	667
2019 Q4	$185K	Sell	13,925 -11,439	-45%	-$126K	﹤0.01%	703
2019 Q3	$217K	Sell	25,364 -11,000	-30%	-$107K	﹤0.01%	676
2019 Q2	$397K	Sell	36,364 -10,875	-23%	-$122K	﹤0.01%	580
2019 Q1	$535K	Buy	47,239 +31,807	+206%	+$355K	﹤0.01%	549
2018 Q4	$133K	Buy	+15,432	New	+$177K	﹤0.01%	756

Other funds holding IRWD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

First Manhattan's IRWD Position: Q4 2023 in Review

First Manhattan sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2023, closing a stake of 28,758 shares — an estimated $277K sold.

First Manhattan first reported a position in IRWD in Q4 2018 and held it in 20 quarters. The position peaked at $535K in Q1 2019. 251 funds tracked by Wall St. Rank hold IRWD as of Q4 2023.

First Manhattan reported no remaining Ironwood Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
First Manhattan sold 28,758 Ironwood Pharmaceuticals shares in Q4 2023, an estimated $277K.
First Manhattan first reported a position in Ironwood Pharmaceuticals in Q4 2018 and held it in 20 quarters.
First Manhattan's Ironwood Pharmaceuticals position peaked at $535K in Q1 2019.
251 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2023.

Based on First Manhattan's 13F filing for Q4 2023, filed 13 Feb 2024.